Latest Content

Kingswood Holdings

Huge ambition with resources available to execute

Kingswood presents investors with a rare opportunity to achieve outsized returns from an institutional grade financial services management team positioned to tap into underlying sector tailwinds in retail wealth management. The largest shareholder, KPI Nominees, has injected and underwritten new capital to establish a robust and efficient operation which is now able to benefit from an additional £80m growth capital from Pollen Street (£4.8m drawn), a global investor with a strong track record in financial services. The group aims to offer best in class, vertically-integrated wealth planning and investment management services backed by leading technology, a rigorous risk and compliance environment and innovative product offerings. Below we outline the potential for this model and note the shares could deliver a medium-term 4.8x return, backed by a UK and US-led acquisition strategy. An exciting first step towards rapid growth.

 View

  • 12 Nov 19
  • -
  • -

Telit Communications Kingswood Holdings

Morning Note – 12 November 2019

Kingswood Holdings (KWG): Corp Huge ambition with resources available to execute | Telit (TCM): Corp YTD trading on track for FY expectations

 View

  • 12 Nov 19
  • -
  • -

PCI Pal Evgen Pharma

Morning Note – 11 November 2019

Evgen Pharma (EVG): Corp Phase IIb SAS data miss primary endpoint | PCI Pal (PCIP): Corp Chairman appointment

 View

  • 11 Nov 19
  • -
  • -

Evgen Pharma

Phase IIb SAS data miss primary endpoint

Evgen announced that the primary endpoint in the Phase IIb SAS study of SFX-01 in sub-arachnoid haemorrhage (SAH) was not achieved, with no significant difference seen between the treatment and placebo arms. Whilst clearly disappointing, our risk-adjusted value (rNPV) for SFX-01 in SAH was 12p. Evgen still has a valuable asset with potential application in breast cancer and other indications. Investors, in our opinion, should not translate the failure of this study to its other clinical programme in metastatic breast cancer. SFX-01 targets a different biological pathway in SAH compared with breast cancer. Equally, risk is reduced further by independent investigator-initiated studies planned for SFX-01 in a range of indications such as NASH and autism, for which Evgen retains all commercial rights. We are reducing our target price to 25p, which reflects the rNPV of SFX-01 in breast cancer whilst also rolling forward the base year to 2020.

 View

  • 11 Nov 19
  • -
  • -

KRM KWG BLV

Morning Note – 7 November 2019

Belvoir Group (BLV): Corp Leveraging internal and external demand | Kingswood Holdings (KWG): Corp First tranche of Pollen Street capital utilised | KRM22 (KRM): Corp Strategic partnership agreement

 View

  • 07 Nov 19
  • -
  • -

IDP IOF MTC

Morning Note – 6 November 2019

InnovaDerma (IDP): Corp AGM – strong start to the year | Iofina (IOF): Corp IofinaEX hemp seed investment | Mothercare (MTC): Corp A critical baby step to become the comeback kid

 View

  • 06 Nov 19
  • -
  • -
 

finnCap Research and Daily Commentaries

Research Tree offers finnCap research, providing ongoing coverage of 278 shares , as well as macro-economic categories including: Commodities - Metals & Mining, Economic Data, and Indices and Markets. We offer 2408 reports from finnCap on Research Tree.

  • Research reports provided by finnCap

  • Companies covered by finnCap

  • Sectors covered by finnCap


Related Content

View the latest research on other companies in the sector. 

Telit Communications Kingswood Holdings

Morning Note – 12 November 2019

Kingswood Holdings (KWG): Corp Huge ambition with resources available to execute | Telit (TCM): Corp YTD trading on track for FY expectations

 View

  • 12 Nov 19
  • -
  • -

PCI Pal Evgen Pharma

Morning Note – 11 November 2019

Evgen Pharma (EVG): Corp Phase IIb SAS data miss primary endpoint | PCI Pal (PCIP): Corp Chairman appointment

 View

  • 11 Nov 19
  • -
  • -

KRM KWG BLV

Morning Note – 7 November 2019

Belvoir Group (BLV): Corp Leveraging internal and external demand | Kingswood Holdings (KWG): Corp First tranche of Pollen Street capital utilised | KRM22 (KRM): Corp Strategic partnership agreement

 View

  • 07 Nov 19
  • -
  • -

IDP IOF MTC

Morning Note – 6 November 2019

InnovaDerma (IDP): Corp AGM – strong start to the year | Iofina (IOF): Corp IofinaEX hemp seed investment | Mothercare (MTC): Corp A critical baby step to become the comeback kid

 View

  • 06 Nov 19
  • -
  • -

BOTB CTP LID

Morning Note – 5 November 2019

Best of the Best (BOTB): Corp Positive end to H1 FY20 confirmed with more profit upgrades | Castleton Technology (CTP): Corp Interims – mapping out a steady second half | LiDCO (LID): Corp China launch

 View

  • 05 Nov 19
  • -
  • -

FOUR AUK LOK ZOO

Morning Note – 4 November 2019

Aukett Swanke (AUK): Corp Positive trading update | Lok'nStore (LOK): Corp Sales, EBITDA and asset values up at double-digit rates | ZOO Digital (ZOO): Corp Interims | 4imprint (FOUR): Corp H2 strong, strategy continues to deliver

 View

  • 04 Nov 19
  • -
  • -